These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 12738113

  • 1. Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus.
    Knudtson E, Para M, Boswell H, Fan-Havard P.
    Obstet Gynecol; 2003 May; 101(5 Pt 2):1094-7. PubMed ID: 12738113
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy.
    Lanzafame M, Rovere P, De Checchi G, Trevenzoli M, Turazzini M, Parrinello A.
    Scand J Infect Dis; 2001 May; 33(6):475-6. PubMed ID: 11450872
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nevirapine-induced side effects in pregnant women: experience of a Brazilian university hospital.
    Kondo W, Carraro EA, Prandel E, Dias JM, Perini J, Macedo RL, Cornelsen TC, Sbalquiero R, Sasaki Md.
    Braz J Infect Dis; 2007 Dec; 11(6):544-8. PubMed ID: 18327464
    [Abstract] [Full Text] [Related]

  • 6. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection.
    Santos RP, Ramilo O, Barton T.
    Pediatr Infect Dis J; 2007 Nov; 26(11):1053-6. PubMed ID: 17984815
    [Abstract] [Full Text] [Related]

  • 7. Nelfinavir and nevirapine side effects during pregnancy.
    Timmermans S, Tempelman C, Godfried MH, Nellen J, Dieleman J, Sprenger H, Schneider ME, de Wolf F, Boer K, van der Ende ME, Dutch HMF Study Group.
    AIDS; 2005 May 20; 19(8):795-9. PubMed ID: 15867493
    [Abstract] [Full Text] [Related]

  • 8. Third-trimester maternal toxicity with nevirapine use in pregnancy.
    Joy S, Poi M, Hughes L, Brady MT, Koletar SL, Para MF, Fan-Havard P.
    Obstet Gynecol; 2005 Nov 20; 106(5 Pt 1):1032-8. PubMed ID: 16260522
    [Abstract] [Full Text] [Related]

  • 9. Safety of nevirapine in pregnancy.
    Natarajan U, Pym A, McDonald C, Velisetty P, Edwards SG, Hay P, Welch J, de Ruiter A, Taylor GP, Anderson J.
    HIV Med; 2007 Jan 20; 8(1):64-9. PubMed ID: 17305934
    [Abstract] [Full Text] [Related]

  • 10. Nevirapine-induced rash with eosinophilia and systemic symptoms (DRESS).
    Gill S, Sagar A, Shankar S, Nair V.
    Indian J Pharmacol; 2013 Jan 20; 45(4):401-2. PubMed ID: 24014920
    [Abstract] [Full Text] [Related]

  • 11. [Cutaneous, hepatic and hematologic manifestations due to nevirapine: DRESS syndrome?].
    Sissoko D, Ajana F, de la Tribonnière X, Baclet V, Mouton Y.
    Presse Med; 2013 Jan 20; 29(19):1041-2. PubMed ID: 10874910
    [Abstract] [Full Text] [Related]

  • 12. Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication.
    Aaron E, Kempf MC, Criniti S, Tedaldi E, Gracely E, Warriner A, Kumar R, Bachmann LH.
    PLoS One; 2010 Sep 07; 5(9):e12617. PubMed ID: 20838641
    [Abstract] [Full Text] [Related]

  • 13. Optimal treatment of nevirapine-associated hepatotoxicity remains uncertain.
    Bundow D, Rosoff L, Aboulafia DM.
    AIDS Read; 2001 Nov 07; 11(11):577-80. PubMed ID: 11789021
    [Abstract] [Full Text] [Related]

  • 14. Liver injury in HIV-1-infected patients receiving non-nucleosides reverse transcriptase inhibitors-based antiretroviral therapy.
    Li ZC, Li HJ, Dai LL, Gao YQ, Cai WP, Li HY, Huang XJ, Zhang T, Wu H.
    Chin Med J (Engl); 2010 Dec 07; 123(24):3587-90. PubMed ID: 22166636
    [Abstract] [Full Text] [Related]

  • 15. DRESS syndrome associated with nevirapine therapy.
    Claudio GA, Martin AF, de Dios Perrino S, Velasco AA.
    Arch Intern Med; 2001 Nov 12; 161(20):2501-2. PubMed ID: 11700164
    [No Abstract] [Full Text] [Related]

  • 16. Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant women.
    Phanuphak N, Apornpong T, Teeratakulpisarn S, Chaithongwongwatthana S, Taweepolcharoen C, Mangclaviraj S, Limpongsanurak S, Jadwattanakul T, Eiamapichart P, Luesomboon W, Apisarnthanarak A, Kamudhamas A, Tangsathapornpong A, Vitavasiri C, Singhakowinta N, Attakornwattana V, Kriengsinyot R, Methajittiphun P, Chunloy K, Preetiyathorn W, Aumchantr T, Toro P, Abrams EJ, El-Sadr W, Phanuphak P.
    HIV Med; 2007 Sep 12; 8(6):357-66. PubMed ID: 17661843
    [Abstract] [Full Text] [Related]

  • 17. Incidence of nevirapine-associated hepatitis in an antenatal clinic.
    Black V, Rees H.
    S Afr Med J; 2008 Feb 12; 98(2):116-8. PubMed ID: 18350206
    [Abstract] [Full Text] [Related]

  • 18. Safety issues about nevirapine administration in HIV-infected pregnant women.
    Manfredi R, Calza L.
    J Acquir Immune Defic Syndr; 2007 Jul 01; 45(3):365-8. PubMed ID: 17592340
    [No Abstract] [Full Text] [Related]

  • 19. Hepatotoxicity with antiretroviral treatment of pregnant women.
    Hill JB, Sheffield JS, Zeeman GG, Wendel GD.
    Obstet Gynecol; 2001 Nov 01; 98(5 Pt 2):909-11. PubMed ID: 11704198
    [Abstract] [Full Text] [Related]

  • 20. [Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].
    Tempelman C, Timmermans S, Godfried MH, Dieleman JP, Boer K, van der Ende ME.
    Ned Tijdschr Geneeskd; 2004 Oct 09; 148(41):2021-5. PubMed ID: 15553999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.